PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Subjects With Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
Clinical trial NCT05007145 · UNKNOWN
Trial details
- NCT number
- NCT05007145
- Sponsor
- Fujian Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-15
- Primary completion
- 2023-08-31
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.